Eligibility Criteria

You are eligible to participate if you meet the following criteria:

• Age ≥ 55; females must be post-menopausal

• DSM-5 criteria for Major Neurocognitive Disorder due to AD; multiple etiologies (AD and vascular)

• sMMSE ≤ 24

• Clinically significant agitation based on IPA definition

• Stable cognition-enhancing medication for at least 3 months prior to study enrolment

• Availability of a caregiver to accompany participant to study visits and to participate in the study

• Ability to speak English

Eligibility Criteria

- are a primary family caregiver of a person with dementia or a related neurodegenerative disorder.

- have access to a computer with high-speed internet; and feel comfortable using email and Zoom (a secure online meeting platform).

- have a video camera on your device. To ensure safety of participants during the program sessions, it is important that participants turn on their video camera. Keeping the video camera on is also important to build trust within the group sessions and when interacting with the researchers.

- are willing to be randomised to one of 3 groups, even if it is not your preferred group.

- are able to commit to a synchronous 8-week online group-based program (described below) and complete daily prescribed daily home practices.

- are able to commit to three assessment sessions: one baseline assessment, one post-program assessment, one 12-month follow-up assessment.

- agree to audio recording of interview sessions and portions of the assessment that require accurate verbal data collection.

- are able to provide blood samples, potentially after a 12-hour fast.

- are able to travel to a LifeLabs clinic for biomarker collection.

- agree to refrain from participating in new studies or programs during the 8-week study session.

- meet the screening criteria during the pre-screening interview.

- ability to speak English.